DPS is characterized by severe, refractory hypoinsulinemic hypoglycemia resulting from the secretion of a prohormone or incompletely processed molecule of insulin-like growth factor (IGF) II, first identified by Daughaday et al. in 1988 [10]. Here, IGF2 is linked to Hypoglycemia.